I do think we have broken the ice on the PR drought despite many positive things happening. Today’s PR was multi purposeful because if they PR long haulers or anything else shorts would say they have failed cd-12 they are not reporting results cause there bad Yada yada yada. I believe today’s PR opens door for them to freely PR any other positive developments from cytodyn because they are not a 1 trick pony as longs know there are 20+ indications that could be updated on. I’m disgusted with today’s short attack but I still have the same amount of shares (actually I added some at $4.20) and all those same shares whether they are $$4 $5 $6 etc will all still be worth $30+ once billions revenue is announced along with EUA ans the future looking very bright to be in confidential discussions with atleast 3 regularity agencies as of this morning and the news was dropped premarket on a Monday morning notorious for positive news however there could be partnership or just national security issues with positive results I know if I was US FDA I wouldn’t delay and let other countries jump in especially since it would be only phase 3 double blinded trial gold standard trail proving reduction in mortality, very limited supply for for world
Wide problem everyone liking for a mortality reducing economic changing drug. FDA ans new administration desperately needs a Win, Leronlimab wil be a huge win. I also think as soon as next week we could be injecting all the long haulers trial patients that they have been prescreening. I believe we will get major media coverage for being first FDA approved long haulers study. I hope that OWS helps with funding because I believe there are millions in grants yet to be given specifically for long haulers